Friday, October 10


Friday, October 10

(The presenters of gray titles did not allow the online appearance of their lectures )


70. INVASION AND METASTASIS

ROOM A, 08.00-12.00 – Friday, October 10

Chair Persons: Y.G. Man, K. Nakamura


71. INVASION AND METASTASIS

ROOM A, 13.00-16.00 Friday, October 10

Chair Persons: A.Z. Dudek, M. Schauer


72. ADVANCES IN GYNECOLOGICAL CANCER

ROOM B, 8.00-12.00 – Friday, October 10

Chair Persons: R. Ganapathi, D. Kieback

  • Gene expression profiling of ovarian cancer: Are we making progress? R. Ganapathi, J. Sehouli, I. E. Braicu and M. Ganapathi (Charlotte, NC, USA; Berlin, Germany) (15’)
  • Next generation expression profiling of primary and recurrent ovarian tumors. M. K. Ganapathi, W. Jones, J. Sehouli, C. M. Michener, I. E. Braicu, C. Biscotti, S. A.J. Vaziri and R. N. Ganapathi (Charlotte; Durham, NC; Cleveland, OH, USA; Berlin, Germany) (15’)
  • The main principles of treatment for the early stage borderline ovarian tumors in women of reproductive age. I.N. Pinchuk , M.A. Liushnenko (Surgut, Russia) (10’)
  • Could HE4 help in decision-making in relation to the individualization of the extent of surgical staging in patients with endometrial cancer. J. Presl, Z. Novotny, O. Topolcan, P. Vlasak, R. Kucera, R. Fuchsova, J. Vrzalova and L. Betincova (Pilen, Czech Republic) (15’)
  • Breast cancer risk prediction: A journey from accurate information on breast cancer diagnosis, to epidemiology and biomarkers. E.O. Fourkala (London, UK) (20’)
  • Modeling for a comprehensive tissue-based repository supporting translational discoveries in ovarian cancer. D. Bassiouny, M. Naeim, S. Nofech-Mozes, N. Ismiil, V. Dubé, G. Han, M. Cesari, E. Slodkowska, F-I. Lu, S. Salama, H.F.Chiu, M.A. Khalifa (Toronto, ON, Canada) (15’)
  • Microcirculation in patients with gynecological cancer. I. Tikhomirova, D. Lileev, N. Kislov, I. Gordeev, M. Schekaleva (Yaroslavl, Russia) (10’)
  • E-cadherin -160 C/A genetic polymorphism and cervical intraepithelial neoplasia. I.C. Rotar, D. Mursan, F. Petrisor, P. Radu, P. Cotutiu, F. Stamatian (Cluj Napoca, Romania) (15′)
  • Borderline ovarian tumors – are they benign or malignant? A. Lazarou, C. Fotopoulou, A. Coumbos, J. Sehouli, J. Vasiljeva, I. Braicu, H. Burger, W. Kuehn (Berlin, Germany) (20’)

73. ADVANCES IN HEAD AND NECK CANCER

ROOM B, 13.00-15.30 – Friday, October 10

Chair Person: S. Syrjänen, K. Syrjänen


74. TUMOR ANGIOGENESIS AND ANTI- ANGIOGENESIS

ROOM C, 08.00-12.00 – Friday, October 10

Chair Persons: S. Kumar, W.G. Jiang, G. Sica


75. MELANOMA: NEW THERAPIES AND BIOMARKERS

ROOM C, 13.00-15.30 – Friday, October 10

Chair Persons: F.J. Lejeune, O. Zoras

  • New Achilles heels in melanoma? F.J. Lejeune (Lausanne, Switzerland) (20′)
  • Isolated limb perfusion with TNFa and melfalan for unresectable melanoma and soft tissue sarcoma. O. Zoras (Heraclion, Greece) (30’)
  • Prognostic value of perioperative assessment of circulating melanoma cells in hyperthermic isolated limb perfusion: interim results. D. Michelakis, I. Messaritakis, K. Lasithiotakis, H. Ioannou, I. Souglakos, D. Stamatiou, O. Zoras (Heraklion, Greece; York, UK) (10′)
  • Comparative metabolomics of primary and metastatic melanoma cells – towards novel diagnostic method. G.K. Ramachandran (Singapore, Singapore) (15′)

76. ADVANCES IN BREAST CANCER

ROOM D, 08.00-12.00 – Friday, October 10

Chair Persons: P.A. Townsend, S. Kraemer


77. ADVANCES IN HEMATO-ONCOLOGY

ROOM D, 13.00-16.00 – Friday, October 10

Chair Persons: A. Polliack, V. Barak, T. Tadmor


78. MICRORNAS IN CANCER

ROOM E, 09.00-11.00 – Friday, October 10

Chair Persons: F. Pentimalli, A. Seth


79. NATURAL PRODUCTS IN CANCER DRUG DEVELOPMENT
Special Symposium Organized by B.A. Littlefield

ROOM F, 09.00-12.30 – Friday, October 10

Chair Persons: M. Postema, J. De Brabander